Safety and pharmacokinetics of bimagrumab in healthy older and obese adults with body composition changes in the older cohort

BACKGROUND: Bimagrumab prevents activity of myostatin and other negative regulators of skeletal muscle mass. This randomized double‐blind, placebo‐controlled study investigated safety, pharmacokinetics (PK), and pharmacodynamics of bimagrumab in healthy older and obese adults. METHODS: A cohort of o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Cachexia Sarcopenia Muscle
Hauptverfasser: Rooks, Daniel, Petricoul, Olivier, Praestgaard, Jens, Bartlett, Michael, Laurent, Didier, Roubenoff, Ronenn
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2020
Schlagworte:
Original Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7749589/
https://ncbi.nlm.nih.gov/pubmed/33264516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12639
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge